Omadacycline Oral Tablet
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Paratek Pharmaceuticals Inc
Overview
Omadacycline Oral Tablet is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Omadacycline Oral Tablet clinical trials
Explore related
Medical disclaimer. This page summarizes research about Omadacycline Oral Tablet for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.